Search for Clinical Trial Results
Mucopolysaccharidosis II - 50 Studies Found
Status | Study |
Recruiting |
Study Name: Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age Condition: Hunter Syndrome Date: 2015-05-20 Interventions: Drug: Elaprase for intravenous (IV) infusion Patients enrolled in this study will receive once-weekly IV |
Completed |
Study Name: Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome Condition: Hunter Syndrome Date: 2011-10-06 Interventions: Other: No treatment |
Completed |
Study Name: Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy Condition:
|
Completed |
Study Name: An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Condition: Hunter Syndrome Date: 2009-04-16 Interventions: Biological: Idursulfase Patients received idursulfase as prescribed by their physician following locally |
Completed |
Study Name: A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® Condition: Hunter Syndrome Date: 2009-06-12 Interventions:
|
Enrolling by invitation |
Study Name: Long-Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Patients With Hunter Syndrome That Have Completed Study HGT-HIT-094 Condition: Hunter Syndrome Date: 2015-04-01 Interventions: Drug: Idursulfase-IT Patients will receive idursulfase-IT treatment once every 28 days at a dose of 10 m |
Completed |
Study Name: Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase® Condition: Hunter Syndrome Date: 2009-07-09 Interventions:
|
Active, not recruiting |
Study Name: Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment Condition: Hunter Syndrome Date: 2014-01-17 Interventions:
|
Active, not recruiting |
Study Name: Extension of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase (IT)in Conjunction With Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment Condition: Hunter Syndrome Date: 2011-12-15 Interventions: Drug: Idursulfase-IT Idursulfase-IT administered once monthly at the dose used in study HGT-HIT-045 via |
Completed |
Study Name: Safety and Efficacy of Hunterase Condition: Hunter Syndrome Date: 2012-07-16 Interventions: Biological: Hunterase once weekly, 0.5mg/kg IV infusion |